TAI NGUYEN: Open Payments
NPI 1275823916 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,442 in 70 payments from 17 companies in 2025. Trend: 2023 $1,477 · 2024 $1,308 · 2025 $1,442
Food & beverage: $1,442
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $347 |
| AstraZeneca Pharmaceuticals LP | 5 | $269 |
| GlaxoSmithKline, LLC. | 11 | $154 |
| Astellas Pharma US Inc | 5 | $98 |
| Lilly USA, LLC | 6 | $95 |
| Vanda Pharmaceuticals Inc. | 3 | $75 |
| Abbott Laboratories | 3 | $62 |
| Ardelyx, Inc. | 2 | $56 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| Exact Sciences Corporation | 3 | $55 |
Products named: FARXIGA, VRAYLAR, QULIPTA, TRELEGY ELLIPTA, Veozah, FANAPT, FREESTYLE LIBRE, IBSRELA.
Industry payments across LA — which companies pay providers there.
